Procter & Gamble Hygiene & Health Care Ltd. AI Stock Analysis
Want to see IN:PGHH full AI Analyst Report?
Procter & Gamble Hygiene & Health Care Ltd. (PGHH) AI Stock Analysis
Procter & Gamble Hygiene & Health Care Ltd.
(NSE:PGHH)
The overall score reflects high‑quality financials as the primary strength, with robust profitability, conservative leverage, and reliable cash generation supporting the investment case. This is offset by very weak technicals, as the stock trades below major moving averages with deeply oversold momentum, signaling near‑term price pressure. Valuation is moderately attractive due to a solid dividend yield, but the relatively elevated P/E limits upside, resulting in a balanced risk–reward profile rather than a top‑tier opportunity.
Procter & Gamble Hygiene & Health Care Ltd. (PGHH) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 228.20B
- Dividend Yield
- 4.17%
- Average Volume (3M)
- 1,343
- Price to Earnings (P/E)
- 29.4
- Beta (1Y)
- 0.40
- Revenue Growth
- -2.00%
- EPS Growth
- -6.04%
- Country
- India
- Employees
- 439
- Sector
- General
- Sector Strength
- 55
- Industry
- Household & Personal Products
Procter & Gamble Hygiene & Health Care Ltd. Business Overview & Revenue Model
Company Description
Established in 1964 and headquartered in Mumbai, India, Procter & Gamble Hygiene and Health Care Limited operates as a subsidiary of Procter & Gamble Overseas India BV. The company specializes in the manufacturing and worldwide distribution of brande...
How the Company Makes Money
PGHH primarily makes money by selling branded consumer products in India, generating revenue from the sale of its hygiene and health care portfolio to distributors, wholesalers, retailers, pharmacies, and other trade customers who then sell to end co...
Procter & Gamble Hygiene & Health Care Ltd. Financial Statement Overview
Summary
Financial performance is strong, with consistently healthy margins, high returns on equity, very low leverage, and solid cash generation, partially tempered by a recent revenue decline and some volatility in cash flow growth.
Income Statement
82Very PositiveBalance Sheet
88Very PositiveCash Flow
79Positive| Breakdown | TTM | Mar 2026 | Mar 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 43.19B | 42.82B | 44.99B | 41.92B | 39.05B | 37.92B |
| Gross Profit | 26.99B | 24.73B | 25.48B | 23.52B | 20.24B | 20.30B |
| EBITDA | 11.78B | 11.97B | 12.11B | 10.23B | 9.09B | 8.54B |
| Net Income | 8.27B | 8.56B | 8.49B | 6.75B | 6.78B | 5.76B |
Balance Sheet | ||||||
| Total Assets | 17.55B | 18.04B | 17.55B | 18.59B | 21.37B | 16.81B |
| Cash, Cash Equivalents and Short-Term Investments | 5.16B | 5.68B | 4.81B | 5.74B | 9.64B | 6.25B |
| Total Debt | 23.20M | 8.70M | 23.20M | 30.80M | 40.30M | 51.00M |
| Total Liabilities | 10.18B | 10.50B | 10.18B | 10.84B | 11.91B | 9.44B |
| Stockholders Equity | 7.37B | 7.53B | 7.37B | 7.75B | 9.46B | 7.38B |
Cash Flow | ||||||
| Free Cash Flow | 6.08B | 8.75B | 5.63B | 4.26B | 7.81B | 5.23B |
| Operating Cash Flow | 6.76B | 9.24B | 6.18B | 4.71B | 8.26B | 5.73B |
| Investing Cash Flow | -586.30M | 113.70M | -586.30M | 10.60M | -99.10M | -268.50M |
| Financing Cash Flow | -6.66B | -8.45B | -6.66B | -8.62B | -4.77B | -5.69B |
Procter & Gamble Hygiene & Health Care Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:PGHH, the sentiment is Negative. The current price of 6879.00 is below the 20-day moving average (MA) of 6984.47, below the 50-day MA of 7153.69, and below the 200-day MA of 9068.49, indicating a neutral trend. The MACD of -9.84 indicates Negative momentum. The RSI at 48.89 is Neutral, neither overbought nor oversold. The STOCH value of 72.65 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:PGHH.
Procter & Gamble Hygiene & Health Care Ltd. Peers Comparison
Overall Rating
IN:HINDUNILVR77Outperform
IN:MARICO73Outperform
IN:COLPAL72Outperform
IN:DABUR70.3Outperform
IN:GODREJCP69Neutral
IN:PGHH69Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 77Outperform | INR 4.66T | 31.09 | ― | 2.05% | 6.41% | 38.32% | |
| 73Outperform | INR 1.17T | 57.77 | ― | 0.44% | 20.05% | 20.83% | |
| 72Outperform | INR 465.79B | 34.23 | ― | 2.80% | 8.72% | 2.71% | |
| 70Outperform | INR 675.88B | 33.32 | ― | 2.36% | 8.94% | 11.89% | |
| 69Neutral | INR 889.90B | 45.05 | ― | 2.29% | 12.02% | 8.49% | |
| 69Neutral | INR 228.28B | 29.42 | ― | 4.17% | -2.00% | -6.04% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:PGHH | Procter & Gamble Hygiene & Health Care Ltd. | 6879.00 | -5702.77 | -45.33% | |
| IN:COLPAL | Colgate-Palmolive (India) Limited | 1702.00 | -419.59 | -19.78% | |
| IN:DABUR | Dabur India Limited | 380.05 | -128.57 | -25.28% | |
| IN:GODREJCP | Godrej Consumer Products Limited | 890.95 | -227.14 | -20.32% | |
| IN:HINDUNILVR | Hindustan Unilever Limited | 1997.00 | -323.55 | -13.94% | |
| IN:MARICO | Marico Limited | 911.00 | 158.19 | 21.01% |
Procter & Gamble Hygiene & Health Care Ltd. Corporate Events
P&G Hygiene Resets Dividend Record Date Ahead of September AGM
Procter & Gamble Hygiene and Health Care Limited has revised the record date for determining shareholders eligible for dividend and participation at its 62nd Annual General Meeting to 1 September 2026. The AGM will be held on 8 September 2026, and, i...
P&G Hygiene Sets AGM and Dividend Timeline for September 2026
Procter & Gamble Hygiene and Health Care Ltd. has scheduled its 62nd Annual General Meeting for September 8, 2026, as disclosed to both BSE and the National Stock Exchange. The company has set September 1, 2026 as the record date for determining shar...
P&G Hygiene and Health Care names new Sales Head as leadership shifts to Korea role
Procter & Gamble Hygiene and Health Care Ltd. announced a leadership transition in its sales function, with seasoned executive Gopalakrishnan Kalianna set to become Sales Head effective August 1, 2026. Kalianna brings over two decades of experience a...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 01, 2026
